S Yoshizawa

Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.

Masami Suganuma, Hirota Fujiki, Hiroko Suguri et al. · Proceedings of the National Academy of Sciences · 1988 · 601 citations · Full text

Medicine, Oncology, Pharmacology +13

Anticentromere Antibody as a Risk Factor for Cancer in Patients with Systemic Sclerosis

Maria de Lourdes Higuchi, Takahiko Horiuchi, Nagisa Ishibashi et al. · Clinical Rheumatology · 2000 · 62 citations

Life Sciences, Immunology, Oncology +6

A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines

Yasuhiro Tamimoto, Takahiko Horiuchi, Hiroshi Tsukamoto et al. · Lara D. Veeken · 2008 · 52 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Mechanisms of action of okadaic acid class tumor promoters on mouse skin.

Hirota Fujiki, Masami Suganuma, S Yoshizawa et al. · Environmental Health Perspectives · 1991 · 47 citations · Full text

Medicine, Oncology, Pharmacology +16

Tumor-promoting activity of staurosporine, a protein kinase inhibitor on mouse skin.

S Yoshizawa, H Fujiki, Hiroko Suguri et al. · PubMed · 1990 · 35 citations

Medicine, Oncology, Pharmacology +12